drugset / Trial / NCT00441207
Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The primary purpose of this study is to evaluate the safety and tolerability of vitamin C (ascorbic acid) given by injection into the vein. The second and third purpose of conducting this study is to observe any evidence of tumor response to the vitamin C and compare the level of fatigue (weakness), pain control, ability to do things, and quality of life, before and after vitamin C is given.
Timeline
- Start
- 2006-08
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin C | Other / unclassified | — | Intravenous |